Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that starting on March 15, 2021, its KOIOS™ nootropic beverage products will be sold in all 11 supermarket locations of Market of Choice, Inc. (“Market of Choice”), a chain of grocery stores in Oregon. With approximately 30 existing retailers of Koios beverages in Oregon (population 4.2 million), the addition of all five KOIOS™ flavours to the in-store offerings of Market of Choice in its 11 locations can further strengthen awareness and adoption of the Company’s products in the Oregon market. With approximately 135 stores also carrying Koios beverages in California and Washington State, this placement adds to the Company’s already strong presence on the west coast of the United States with a nationwide total of more than 4,000 stores that sell Koios products.

Market of Choice was founded in 1979 with a single location in Cottage Grove, Oregon under the name of Thriftway Market. After acquiring several other grocery stores which operated under the Price Chopper and PC Market banners, the Market of Choice identity was introduced in 2000 in response to demand from patrons for a greater selection of natural and organic products alongside conventional grocery offerings1. As of 2021, Market of Choice employs over 1,400 Oregonians and has locations in Ashland, Belmont, Bend, Cedar Mill, Corvallis, Delta Oaks, Franklin, Medford, West Linn, Willakenzie, and Willamette. Over 7,000 local products are sold at Market of Choice supermarkets in traditional grocery categories as well as homewares, beer and wine, and whole health2. In 2008 Market of Choice made local headlines for its decision to abandon plastic shopping bags at its checkouts, inspired by natural foods giant Whole Foods who also eliminated plastic bags from its stores in the United States, Canada, and the United Kingdom earlier in the same year3.

Keep reading... Show less

Emerging leader in health and wellness beverages and products, BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to announce that it has added glass manufacturing capabilities to its industry leading high-capacity beverage facility, creating the only full service manufacturing facility with the ability to produce PET, aluminum, and glass form factors, available in multiple sizes and custom shapes.

The Company also announces that is has entered into the following agreements:

Keep reading... Show less

Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the “Company” or “Canntab“), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is thrilled to announce the Canadian Intellectual Property Office (“CIPO“) has allowed Canadian Patent No. CA 3050150 to Canntab, related to its proprietary cannabidiol formulations with a priority date of January 23, 2017. The term of the patent expires on January 22, 2038.

Canntab’s Legal Counsel on intellectual property, Gavin Bogle of Magyar, Bogle & O’Hara LLP said, “The allowance of Canntab’s patent by the Canadian Intellectual Property Office provides fundamental intellectual protection for Canntab’s innovative tableting technology and validates the years of research and development the company has conducted. The Company now has patent protection in Canada and the USA providing an international scope to the Company’s expanding portfolio of issued patents.”

Keep reading... Show less

Redfund Capital Corp. (CSE:LOAN, Frankfurt:O3X4, OTCQB:PNNRF) (Redfund or the “Company”) is pleased to announce CannaForum BV “CANNA” our newest portfolio client, has been notified it remains in the last 40 cannabis applications and that over 100 other submissions have been rejected to date by the Dutch government in their Closed Cannabis Supply Chain Experiment.

Redfund previously announced on July 29 that the Company had signed a letter of intent with CannaForum BV a company registered in the Netherlands, that had submitted an application for a cannabis cultivation license to the Dutch government in a new experiment program for the legal cultivation of cannabis in the Netherlands. Redfund and CannaForum have begun discussing a definitive agreement and terms will be disclosed when appropriate. 10 Cannabis producers will be awarded licenses in early 2021 and will be the only companies allowed to legally operate from 2021 to at least 2025 in the Netherlands. The Dutch experiment includes 79 retailers / `Coffeeshops’ within 10 selected cities. All retailers in the experiment are required to purchase all their products from the 10 selected producers. According to the application submitted to the Netherlands government, a minimum of 65.000 kg is required to be produced by 10 producers on an annual basis to supply all 79 retailers. For each producer: 6.500 kg at current Dutch wholesale prices translates to approx. 12-20m revenues annually.

Keep reading... Show less

FSD Pharma Inc. (formerly, Century Financial Capital Group Inc., the “Corporation”) is pleased to announce that it has completed its previously announced business combination with FV Pharma Inc. (“FV Pharma”). On March 9, 2018 the Corporation and FV Pharma entered into an arm’s length definitive business combination agreement (the “Business Combination Agreement”) with 2620756 Ontario Inc. (“SubCo”), a wholly-owned subsidiary of the Corporation, incorporated for the purpose of this transaction. Pursuant to the Business Combination Agreement, the Corporation changed its name to FSD Pharma Inc. and completed a business combination with FV Pharma by way of a three-cornered amalgamation pursuant to which FV Pharma amalgamated with SubCo (the “Transaction”). The resulting amalgamated corporation carried on in the name of FV Pharma as a wholly-owned subsidiary of the Corporation. Following the completion of the Transaction, FSD Pharma Inc. will carry on the medical cannabis business of FV Pharma. For the purposes of this press release, the term “Resulting Issuer” means the Corporation following completion of the Transaction.

On March 15, 2018, the Corporation held an annual and special meeting of the shareholders of the Corporation (the “Shareholders”), where the Shareholders approved a share re-designation, a name change, and other matters relating to the Transaction.

Keep reading... Show less

Naturally Splendid Enterprises Ltd. (“Naturally Splendid”, “NSE” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) is pleased to announce that Naturally Splendid Director and President of the Canadian Hemp Trade Alliance (CHTA), Mr. Russ Crawford, was a key speaker at the recent Senate hearing on May 23rd, 2018, to review hemp and its inclusion under Bill C-45 the Cannabis Act.

Representing the CHTA, Mr. Crawford acknowledged the fine work of the Marijuana Task Force in developing Proposed Regulations for the new Act which include important changes and reduced regulation for the production, processing and commercial sale of industrial hemp. The CHTA spoke in favour of Senate support for Bill C-45 which will provide a less regulated commercial environment for the hemp industry in Canada.

Keep reading... Show less